Blog Posts
Bishal Gyawali, Editorial Board
Bishal Gyawali/scri.queensu.ca

Bishal Gyawali: WHO EML working group discussion on checkpoint inhibitors for solid cancers

Bishal Gyawali, Associate Professor at Queen’s University, shared a post on LinkedIn:

“I hope you take some time to read our deliberations and discussions at the WHO EML cancer drugs working group meeting re checkpoint inhibitors in treating solid cancers.”

Read further.

Bishal Gyawali: WHO EML working group discussion on checkpoint inhibitors for solid cancers

More posts featuring Bishal Gyawali.

Bishal Gyawali cancer checkpoint inhibitors OncoDaily Oncology solid cancers WHO EML